Lonza’s Advanced Synthesis family of solutions for testing and optimizing synthetic processes assist drug developers in navigating the path from discovery to commercialization.
As small-molecule APIs become more complex, AI-enabled route scouting, HTE, and the Design2Optimize™ platform improve manufacturability, commercial viability, and other key factors without sacrificing time or resource efficiency. These capabilities help the next generation of innovative therapies reach patients faster.
Read the white paper to learn more about modern tools that can help you evaluate and optimize process chemistry.